Acadian Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,120
Closed -$325K 2435
2020
Q4
$325K Buy
+4,120
New +$242K ﹤0.01% 1374
2018
Q1
Sell
-3,003
Closed -$309K 1910
2017
Q4
$309K Buy
+3,003
New +$299K ﹤0.01% 892
2017
Q1
Sell
-17
Closed -$1K 1849
2016
Q4
$1K Buy
+17
New +$1.32K ﹤0.01% 1610
2016
Q3
Sell
-3
Closed 1598
2016
Q2
$0 Sell
3
-161
-98% -$11.1K ﹤0.01% 1578
2016
Q1
$12K Hold
164
﹤0.01% 1171
2015
Q4
$10K Buy
+164
New +$10K ﹤0.01% 1242

Other funds holding CMD

Acadian Asset Management's CMD Position: Q1 2021 in Review

Acadian Asset Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 4,120 shares — an estimated $325K sold.

Acadian Asset Management first reported a position in CMD in Q4 2015 and held it in 6 quarters. The position peaked at $325K in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Acadian Asset Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 4,120 Cantel Medical Corporation shares in Q1 2021, an estimated $325K.
  • Acadian Asset Management first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 6 quarters.
  • Acadian Asset Management's Cantel Medical Corporation position peaked at $325K in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.